Header Logo

Connection

ELENA GRIGORENKO to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications ELENA GRIGORENKO has written about Reverse Transcriptase Inhibitors.
ELENA GRIGORENKO
Connection Strength
0.735
Reverse Transcriptase Inhibitors
  1. The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long-Term ARV Treatment. New Dir Child Adolesc Dev. 2020 May; 2020(171):107-133.
    View in: PubMed
    Score: 0.735
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.